About the Webinar

Now more than ever, clinicians must understand the non-clinical factors that influence and often determine a patient’s health outcomes. As organizations expand their approach to population health management, one thing is sure; they cannot underestimate the importance of identifying social risk and building partnerships with community agencies and social services to address this risk. Whether this means identifying high-risk patients with a stratification model based on non-clinical factors or enabling a meaningful conversation about social vulnerabilities between the doctor and patient, providers can leverage AI and Machine Learning technology, along with non-traditional, activated data to impact the health of their populations and win at Value-Based Care.

In this webinar, Mark Ganz, Former CEO at Cambia Health Solutions, Kevin F. Brennan, Senior Advisor to McKinsey and Company, and David Nace, MD, Chief Medical Officer, Innovaccer Inc., will explore how the COVID-19 pandemic has changed the non-clinical landscape of healthcare and made it necessary to address these underlying social determinants of health.

You will learn

  • How has the pandemic affected our consideration of the SDoH policies and programs of healthcare organizations?
  • What will be the financial implications that SDoH factors will have on the care delivery system in the future?
  • How do we fast-track the measurement and management of SDoH and move this into the population health management workflow?
  • What types of innovations and partnerships are vital to sustaining momentum and focus on integrating medical, social, and other community-based services to deliver the “whole person care?”
  • What are the financial considerations in addressing health equity?
  • What role do virtual care services play in measuring and managing risk? How does it impact our outcomes? Our predictive models?
  • What are the next steps to succeed, both clinically and financially in the post-pandemic environment? What changes are likely here to stay—and which will likely end in the upcoming years?

Register for the Virtual Session

Please enter valid name.
Please enter a valid email address.
Please enter valid contact number.

About the Webinar

Now more than ever, clinicians must understand the non-clinical factors that influence and often determine a patient’s health outcomes. As organizations expand their approach to population health management, one thing is sure; they cannot underestimate the importance of identifying social risk and building partnerships with community agencies and social services to address this risk. Whether this means identifying high-risk patients with a stratification model based on non-clinical factors or enabling a meaningful conversation about social vulnerabilities between the doctor and patient, providers can leverage AI and Machine Learning technology, along with non-traditional, activated data to impact the health of their populations and win at Value-Based Care.

In this webinar, Mark Ganz, Former CEO at Cambia Health Solutions, Kevin F. Brennan, Senior Advisor to McKinsey and Company, and David Nace, MD, Chief Medical Officer, Innovaccer Inc., will explore how the COVID-19 pandemic has changed the non-clinical landscape of healthcare and made it necessary to address these underlying social determinants of health.

You will learn

  • How has the pandemic affected our consideration of the SDoH policies and programs of healthcare organizations?
  • What will be the financial implications that SDoH factors will have on the care delivery system in the future?
  • How do we fast-track the measurement and management of SDoH and move this into the population health management workflow?
  • What types of innovations and partnerships are vital to sustaining momentum and focus on integrating medical, social, and other community-based services to deliver the “whole person care?”
  • What are the financial considerations in addressing health equity?
  • What role do virtual care services play in measuring and managing risk? How does it impact our outcomes? Our predictive models?
  • What are the next steps to succeed, both clinically and financially in the post-pandemic environment? What changes are likely here to stay—and which will likely end in the upcoming years?

About the Presenters

Mark Ganz
Mark Ganz
Former CEO at Cambia Health Solutions, Joins Innovaccer's Strategic Advisory Board

Ganz brings more than 25 years of healthcare leadership experience to help Innovaccer build the future of health on the Innovaccer Health Cloud. SAN FRANCISCO, CA, JUNE XX, 2021 — Leading healthcare technology company, Innovaccer Inc. announced that Mark Ganz, former CEO at Cambia Health Solutions, will join its Strategic Advisory Board. In his new role, Ganz will help Innovaccer drive innovation and advance the Innovaccer Health Cloud, the company’s platform for powering the future of health. Ganz has more than 25 years of leadership experience at several payer and provider healthcare organizations. He is a board member at Portland General Electric, the University of Portland, the Cascade Pacific Council, Boy Scouts of America, Tournament Golf Foundation, and the Coalition to Transform Advanced Care (C-TAC). He is also a member of the Healthcare Executives Study Society, the Health Evolution Summit leadership circle, and the Aspen Group, an interdisciplinary group of senior leaders in healthcare policy and innovation. For two decades, Ganz led Cambia in reimagining and reshaping healthcare to be more empathetic, transparent, and economically sustainable. Under Mark’s leadership Cambia was one of only 125 global companies to receive designation as the World’s Most Ethical Corporations (3 year recipient). He was recognized by Modern Healthcare magazine as one of the “100 Most Influential in Health Care” in 2018 and 2019. He has also received the Health Care Transformer of the Year award, the Oregon Governors’ Gold Award, and a Sojourns Award in 2020. Ganz has been a long time advocate for patient-centered and economically sustainable healthcare transformation for individuals and families in the U.S. His leadership experience and ability to scale cost-effective and profitable growth strategies will help Innovaccer eliminate data barriers in the U.S. healthcare system. His vision aligns with the company’s mission of connecting and curating the world’s data to make it accessible and useful. “In addition to Innovaccer’s technical prowess, the company is deeply committed to making a substantial difference for individuals and families in healthcare,” said Ganz. “The company is passionate about creating a singular and integrated experience for people in their healthcare journeys. I’m excited to join them in their efforts.” “Healthcare is undergoing rapid transformation, and companies need to harness the power of data to improve both clinical and financial outcomes,” said Abhinav Shashank, CEO at Innovaccer. “We are proud to be working with many of the leading companies across healthcare to help them unify their data silos, create a holistic view of their patients, and accelerate digital transformation. I’m thrilled to welcome Mark to the team and confident that his guidance will support our efforts to build the future of health on the Innovaccer Health Cloud.”

Kevin F. Brennan
Kevin F. Brennan
Senior Advisor to McKinsey and Company

Mr. Brennanserves as a Senior Advisor to McKinsey & Co and advises on a broad range of strategic and operational engagements.He also serves as a Principal with SunStone Consultingassisting clients throughout the country with reimbursement, regulatory, revenue integrity, and strategic solutions. For 23 years, thru June 2018, Mr.Brennan served as theExecutive Vice President ofFinanceand Chief Financial Officerof Geisinger –a$7 billionphysician-led,integrated health services organization that has as its main componentsan array of health services providers, including hospitals, a physician group practice,a number of health insurance companies and a medicalschool.Before his tenure with Geisinger Health System, he served as a CFO with other large health systems and tertiary care hospitals. Mr. Brennan servedasthe National Chairof the 50,000 member Healthcare Financial Management Association (HFMA) for the 2018-2019 year, following two years as an Officer and three years on the Board of Directors. Mr. Brennan has been a member of HFMA since 1981 and a Fellow since 1992. He was an active member of HFMA’s Large System CFO Council, the Value Projects and previously served on the Principlesand PracticesBoard, the Patient Transparency TaskForce and was a board member of the Metropolitan Philadelphia Chapter. Mr. Brennan holds a Master of Business Administration degree in Healthcare Administration and a Bachelor of Science degree in Business Administration, both from LaSalle University in Philadelphia. He has been a Certified Public Accountant since 1979 and is a member of thethe Pennsylvania Institute of Certified Public Accountants.

David Nace MD
David Nace MD
Chief Medical Officer at Innovaccer, Former VP & CMO at Aetna, & Former VP at McKesson

Dr. David Nace is the Chief Medical Officer at Innovaccer where its category creating healthcare data activation platform is on a mission to organize healthcare information and make it accessible, useful, and actionable. Dr. Nace has over 25 years of executive management experience in large healthcare systems, payer health plans, and leading healthcare provider and health information technology organizations. With strong collaborative and cross-functional leadership skills, he previously served as SVP, CMO with United Health Group and VP, CMO with Aetna, and CMO at McKesson. Dr. Nace earned his medical degree from the University of Pittsburgh.